Twist Bioscience Corp (NAS:TWST)
$ 46.39 -0.69 (-1.47%) Market Cap: 2.72 Bil Enterprise Value: 2.52 Bil PE Ratio: 0 PB Ratio: 5.53 GF Score: 85/100

Twist Bioscience Corp Twist Biopharma Analyst & Investor Event Transcript

Oct 23, 2020 / 03:00PM GMT
Release Date Price: $85.97 (-1.25%)
Operator

Good morning, and welcome to the Twist Biopharma Virtual Biopharma Analyst & Investor Event. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Emily Leproust, Chief Executive Officer of Twist Bioscience. Please go ahead.

Emily Marine Leproust
Twist Bioscience Corporation - Co-Founder, Chairman, President & CEO

Good morning, everybody, and good afternoon, if you are in Europe or Asia. It's my great pleasure to host you today for our Virtual Biopharma Analyst & Investor Event. As you know, biopharma is becoming an important part of Twist, and we thought it would be useful to you to hear from some of our customers about what they do with our platform and the benefit that it brings to their work and their companies.

So with that, we go to the next slide, and I will mention, first, that we will be making some forward-looking statements today.

Next, I'd like to very quickly go over the agenda. So I'll give you a brief welcome and Twist overview. Then we'll hear

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot